Jefferies analyst Chris Counihan downgraded Arkema (ARKAY) to Hold from Buy with a price target of EUR 65, down from EUR 80. The firm adjusted ratings in European chemicals, saying it continues to favor consumer ingredients while seeing a challenged outlook for diversified names. Ingredients companies should again deliver good organic sales growth in second half of 2025, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARKAY:
- Arkema price target lowered to EUR 88 from EUR 97 at Berenberg
- Arkema price target lowered to EUR 65 from EUR 68.50 at JPMorgan
- Arkema S.A. Q1 2025 Earnings Call Highlights Mixed Sentiments
- Arkema price target lowered to EUR 99 from EUR 104 at Morgan Stanley
- Arkema S.A. Reports Resilient Q1 2025 Performance